Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
419 | 28518 | 42.4 | 80% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
419 | 3 | ADENOVIRUS//MERKEL CELL CARCINOMA//GENE THERAPY | 28518 |
564 | 2 | GENE THERAPY//ADENOVIRUS//HUMAN GENE THERAPY | 14456 |
1238 | 2 | MERKEL CELL CARCINOMA//POLYOMAVIRUS//JC VIRUS | 9044 |
2151 | 2 | ADENOVIRUS//E1A//EPIDEMIC KERATOCONJUNCTIVITIS | 5018 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ADENOVIRUS | authKW | 856868 | 7% | 40% | 2014 |
2 | MERKEL CELL CARCINOMA | authKW | 530410 | 2% | 86% | 575 |
3 | GENE THERAPY | authKW | 468657 | 9% | 18% | 2520 |
4 | POLYOMAVIRUS | authKW | 460862 | 2% | 79% | 546 |
5 | JC VIRUS | authKW | 402348 | 1% | 91% | 413 |
6 | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | authKW | 373659 | 1% | 82% | 424 |
7 | BK VIRUS | authKW | 370205 | 1% | 89% | 390 |
8 | HUMAN GENE THERAPY | journal | 310289 | 3% | 30% | 985 |
9 | ONCOLYTIC VIRUS | authKW | 253380 | 1% | 71% | 335 |
10 | VIROLOGY | WoSSC | 234243 | 22% | 4% | 6277 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Virology | 234243 | 22% | 4% | 6277 |
2 | Medicine, Research & Experimental | 63213 | 18% | 1% | 5221 |
3 | Biotechnology & Applied Microbiology | 46963 | 18% | 1% | 5185 |
4 | Genetics & Heredity | 42685 | 17% | 1% | 4872 |
5 | Oncology | 18594 | 15% | 1% | 4269 |
6 | Biochemistry & Molecular Biology | 6782 | 17% | 0% | 4838 |
7 | Cell Biology | 5580 | 9% | 0% | 2602 |
8 | Transplantation | 4923 | 3% | 1% | 890 |
9 | Immunology | 2398 | 6% | 0% | 1794 |
10 | Pathology | 1321 | 3% | 0% | 754 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GENE THER Y | 228564 | 3% | 28% | 759 |
2 | HUMAN GENE THER Y | 164607 | 1% | 48% | 323 |
3 | CANC GENE THER Y GRP | 79019 | 0% | 70% | 105 |
4 | GENE THER Y PROGRAM | 62232 | 1% | 33% | 177 |
5 | POWELL GENE THER Y | 49907 | 0% | 38% | 123 |
6 | SAN DIEGO SCI | 35205 | 0% | 63% | 52 |
7 | MOL MED NEUROSCI | 30365 | 0% | 46% | 62 |
8 | CELLULAR MOL THER Y | 30062 | 0% | 46% | 61 |
9 | GENE TRANSFER REGULAT | 27188 | 0% | 58% | 44 |
10 | MOL MED GENE THER Y UNIT | 22308 | 0% | 67% | 31 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HUMAN GENE THERAPY | 310289 | 3% | 30% | 985 |
2 | GENE THERAPY | 279427 | 4% | 26% | 1013 |
3 | MOLECULAR THERAPY | 189800 | 3% | 22% | 795 |
4 | JOURNAL OF VIROLOGY | 185033 | 9% | 7% | 2634 |
5 | CANCER GENE THERAPY | 183628 | 2% | 30% | 581 |
6 | VIROLOGY | 68239 | 4% | 6% | 1100 |
7 | JOURNAL OF GENE MEDICINE | 59659 | 1% | 20% | 281 |
8 | HUMAN GENE THERAPY METHODS | 27123 | 0% | 39% | 65 |
9 | CURRENT GENE THERAPY | 23853 | 0% | 20% | 111 |
10 | JOURNAL OF NEUROVIROLOGY | 15936 | 1% | 10% | 150 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADENOVIRUS | 856868 | 7% | 40% | 2014 | Search ADENOVIRUS | Search ADENOVIRUS |
2 | MERKEL CELL CARCINOMA | 530410 | 2% | 86% | 575 | Search MERKEL+CELL+CARCINOMA | Search MERKEL+CELL+CARCINOMA |
3 | GENE THERAPY | 468657 | 9% | 18% | 2520 | Search GENE+THERAPY | Search GENE+THERAPY |
4 | POLYOMAVIRUS | 460862 | 2% | 79% | 546 | Search POLYOMAVIRUS | Search POLYOMAVIRUS |
5 | JC VIRUS | 402348 | 1% | 91% | 413 | Search JC+VIRUS | Search JC+VIRUS |
6 | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | 373659 | 1% | 82% | 424 | Search PROGRESSIVE+MULTIFOCAL+LEUKOENCEPHALOPATHY | Search PROGRESSIVE+MULTIFOCAL+LEUKOENCEPHALOPATHY |
7 | BK VIRUS | 370205 | 1% | 89% | 390 | Search BK+VIRUS | Search BK+VIRUS |
8 | ONCOLYTIC VIRUS | 253380 | 1% | 71% | 335 | Search ONCOLYTIC+VIRUS | Search ONCOLYTIC+VIRUS |
9 | ADENO ASSOCIATED VIRUS | 208129 | 2% | 41% | 479 | Search ADENO+ASSOCIATED+VIRUS | Search ADENO+ASSOCIATED+VIRUS |
10 | NATALIZUMAB | 177603 | 1% | 55% | 302 | Search NATALIZUMAB | Search NATALIZUMAB |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MARSHALL, LJ , NELSON, CDS , ATWOOD, WJ , NATH, A , KHALILI, K , MAJOR, EO , FERENCZY, MW , (2012) MOLECULAR BIOLOGY, EPIDEMIOLOGY, AND PATHOGENESIS OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY, THE JC VIRUS-INDUCED DEMYELINATING DISEASE OF THE HUMAN BRAIN.CLINICAL MICROBIOLOGY REVIEWS. VOL. 25. ISSUE 3. P. 471 -+ | 397 | 82% | 95 |
2 | COUGHLAN, L , ALBA, R , PARKER, AL , BRADSHAW, AC , MCNEISH, IA , NICKLIN, SA , BAKER, AH , (2010) TROPISM-MODIFICATION STRATEGIES FOR TARGETED GENE DELIVERY USING ADENOVIRAL VECTORS.VIRUSES-BASEL. VOL. 2. ISSUE 10. P. 2290 -2355 | 323 | 88% | 34 |
3 | LION, T , (2014) ADENOVIRUS INFECTIONS IN IMMUNOCOMPETENT AND IMMUNOCOMPROMISED PATIENTS.CLINICAL MICROBIOLOGY REVIEWS. VOL. 27. ISSUE 3. P. 441 -462 | 199 | 80% | 56 |
4 | LYNCH, JP , KAJON, AE , (2016) ADENOVIRUS: EPIDEMIOLOGY, GLOBAL SPREAD OF NOVEL SEROTYPES, AND ADVANCES IN TREATMENT AND PREVENTION.SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE. VOL. 37. ISSUE 4. P. 586 -602 | 249 | 89% | 0 |
5 | HIRSCH, HH , KARDAS, P , KRANZ, D , LEBOEUF, C , (2013) THE HUMAN JC POLYOMAVIRUS (JCPYV): VIROLOGICAL BACKGROUND AND CLINICAL IMPLICATIONS.APMIS. VOL. 121. ISSUE 8. P. 685-727 | 204 | 94% | 37 |
6 | DE GASCUN, CF , CARR, MJ , (2013) HUMAN POLYOMAVIRUS REACTIVATION: DISEASE PATHOGENESIS AND TREATMENT APPROACHES.CLINICAL & DEVELOPMENTAL IMMUNOLOGY. VOL. . ISSUE . P. - | 235 | 87% | 12 |
7 | RUSSELL, WC , (2009) ADENOVIRUSES: UPDATE ON STRUCTURE AND FUNCTION.JOURNAL OF GENERAL VIROLOGY. VOL. 90. ISSUE . P. 1 -20 | 200 | 91% | 112 |
8 | LYNCH, JP , FISHBEIN, M , ECHAVARRIA, M , (2011) ADENOVIRUS.SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE. VOL. 32. ISSUE 4. P. 494 -511 | 170 | 91% | 76 |
9 | TEUNISSEN, EA , DE RAAD, M , MASTROBATTISTA, E , (2013) PRODUCTION AND BIOMEDICAL APPLICATIONS OF VIRUS-LIKE PARTICLES DERIVED FROM POLYOMAVIRUSES.JOURNAL OF CONTROLLED RELEASE. VOL. 172. ISSUE 1. P. 305-321 | 190 | 87% | 20 |
10 | IMPERIALE, MJ , JIANG, MX , ABEND, JR , JOHNSON, SF , (2009) THE ROLE OF POLYOMAVIRUSES IN HUMAN DISEASE.VIROLOGY. VOL. 384. ISSUE 2. P. 266 -273 | 150 | 98% | 127 |
Classes with closest relation at Level 3 |